Clinical Trials Directory

Trials / Completed

CompletedNCT03438084

The INTER-CARDIO Study: The Impact of Commonly Consumed Fat on Cardiovascular Health; a Randomised Controlled Trial

The INTER-CARDIO Study: The Impact of Commonly Consumed Fat on Cardiovascular

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
King's College London · Academic / Other
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate whether there are differences in postprandial cardiometabolic metabolic indices following interesterified fats used commercially versus application appropriate non- interesterifed alternative fat.

Detailed description

Aim: The current study aims to investigate the acute effects of commercially available interesterified fat versus versus application appropriate non- interesterifed alternative fat on 8 h postprandial cardiometabolic outcomes. Hypothesis: Interesterified fat will induce a different cardiomtabolic response compared to a non interesterifed, application appropriate fat. Subjects: Participants will include 40 healthy male and female volunteers aged between the ages of 35 and 75 years (since during this age metabolic changes start to take place). Power calculation: Based on previous studies carried out by our group at King's College London, a sample size of 20 participants (males and females separately) will allow a 2.16% (percentage unit) difference in FMD to be detected (90% power, 0.05 alpha, SD 2.9. 50 participants will be recruited allowing for a 20% dropout rate. Expected value:The study will provide novel information on the acute effects of commercially relevant processed fats on postprandial lipaemia.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTInteresterified fat50 g fat provided as commercially available interesterified fat.
DIETARY_SUPPLEMENTNon- interesterified fat50 g fat provided as commercially available non-interesterified fat.
DIETARY_SUPPLEMENTRapeseed oil50 g fat provided as commercially available rapeseed oil.
DIETARY_SUPPLEMENTButter50g fat provided as commercially available spreadable butter

Timeline

Start date
2018-07-01
Primary completion
2019-10-01
Completion
2019-10-31
First posted
2018-02-19
Last updated
2020-01-27

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03438084. Inclusion in this directory is not an endorsement.